학술논문
SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome
Document Type
Article
Author
Source
In: Clinical Lymphoma, Myeloma and Leukemia . (Clinical Lymphoma, Myeloma and Leukemia, December 2022, 22(12):e1059-e1066)
Subject
Language
English
ISSN
21522669
21522650
21522650